Leica Biosystems Completes Acquisition of StatLab to Bolster Delivery of More Precise, Timely Diagnostics for Cancer Patients

Leica Biosystems completes acquisition of StatLab to bolster delivery of more precise, timely diagnostics for cancer patients

Leica Biosystems, a Danaher company (the “Company”) and a global leader in digital and anatomic pathology solutions advancing precision cancer diagnostics, announced today that the Company has completed its acquisition of privately held StatLab Medical Products (“StatLab”).

Leica Biosystems Acquires StatLab Medical Products

Leica Biosystems has acquired StatLab Medical Products, expanding its anatomic pathology portfolio with pre-analytical consumables and equipment to support clinical histology workflows.

Leica Biosystems completes acquisition of StatLab

Leica Biosystems, a Danaher company, announced that the Company has completed its acquisition of privately held StatLab, a provider of pre-analytical consumables and equipment, from Linden Capital Partners and Audax Private Equity.

Leica Biosystems Enhances Cancer Diagnostics With Exciting Acquisition

Acquisition advances Leica Biosystems' end-to-end anatomic pathology ecosystem, expanding integrated solutions that help laboratories move from sample to answer with speed and confidence for the clinicians and patients who depend on them <p>The post Leica Biosystems Completes Acquisition of StatLab to Bolster Delivery of More Precise, Timely Diagnostics for Cancer Patients first appeared on Medical Device News Magazine.</p>